_id

690da8c5ccc777a4e85d0804

Ticker

ACET

Name

Adicet Bio Inc

Exchange

NASDAQ

Address

131 Dartmouth Street, Boston, MA, United States, 02116

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.adicetbio.com

Description

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.

Last Close

0.5487

Volume

4710390

Current Price

0.5168

Change

-5.813741570985955

Last Updated

2025-11-28T11:47:06.506Z

Image

-

Ipo Date

2018-01-26T00:00:00.000Z

Market Cap

92106608

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.98

Sentiment Sources

1

Rating

4.7143

Target Price

7.1667

Strong Buy

6

Buy

0

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

1600000

Gross Profit

-1600000

Operating Expenses

27952000

Operating Income

-27952000

Interest Expense

12000

Pretax Income

-26856000

Net Income

-26856000

Eps

-0.2948407350624567

Dividends Per Share

-

Shares Outstanding

153255581

Income Tax Expense

-

EBITDA

-25271000

Operating Margin

-

Total Other Income Expense Net

1096000

Cash

29099000

Short Term Investments

73999000

Receivables

169000

Inventories

-

Total Current Assets

106494000

Property Plant Equipment

30972000

Total Assets

140479000

Payables

4287000

Short Term Debt

3265000

Long Term Debt

-

Total Liabilities

31337000

Equity

109142000

Depreciation

868000

Change In Working Capital

1637000

Cash From Operations

-22307000

Capital Expenditures

209000

Cash From Investing

16836000

Cash From Financing

-150000

Net Change In Cash

-5621000

PE

-

PB

0.4313049476388558

ROE

-24.60647596708875

ROA

-19.117448159511387

FCF

-22516000

Fcf Percent

-

Piotroski FScore

1

Health Score

42

Deep Value Investing Score

5.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

4

Quality Investing Score

2.5

Value Investing Score

5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

1600000

Quarters > 0 > income Statement > gross Profit

-1600000

Quarters > 0 > income Statement > operating Expenses

27952000

Quarters > 0 > income Statement > operating Income

-27952000

Quarters > 0 > income Statement > interest Expense

12000

Quarters > 0 > income Statement > pretax Income

-26856000

Quarters > 0 > income Statement > net Income

-26856000

Quarters > 0 > income Statement > eps

-0.2948407350624567

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

91086464

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-25271000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1096000

Quarters > 0 > balance Sheet > cash

29099000

Quarters > 0 > balance Sheet > short Term Investments

73999000

Quarters > 0 > balance Sheet > receivables

169000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

106494000

Quarters > 0 > balance Sheet > property Plant Equipment

30972000

Quarters > 0 > balance Sheet > total Assets

140479000

Quarters > 0 > balance Sheet > payables

4287000

Quarters > 0 > balance Sheet > short Term Debt

3265000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

31337000

Quarters > 0 > balance Sheet > equity

109142000

Quarters > 0 > cash Flow > net Income

-26856000

Quarters > 0 > cash Flow > depreciation

868000

Quarters > 0 > cash Flow > change In Working Capital

1637000

Quarters > 0 > cash Flow > cash From Operations

-22307000

Quarters > 0 > cash Flow > capital Expenditures

209000

Quarters > 0 > cash Flow > cash From Investing

16836000

Quarters > 0 > cash Flow > cash From Financing

-150000

Quarters > 0 > cash Flow > net Change In Cash

-5621000

Quarters > 0 > ratios > PE

-0.2948407350624567

Quarters > 0 > ratios > PB

0.4313049476388558

Quarters > 0 > ratios > ROE

-24.60647596708875

Quarters > 0 > ratios > ROA

-19.117448159511387

Quarters > 0 > ratios > FCF

-22516000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

42

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

1600000

Quarters > 1 > income Statement > gross Profit

-1600000

Quarters > 1 > income Statement > operating Expenses

32392000

Quarters > 1 > income Statement > operating Income

-32392000

Quarters > 1 > income Statement > interest Expense

0

Quarters > 1 > income Statement > pretax Income

-31217000

Quarters > 1 > income Statement > net Income

-31217000

Quarters > 1 > income Statement > eps

-0.3427219254839513

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

91085506

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-29562000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

1175000

Quarters > 1 > balance Sheet > cash

34720000

Quarters > 1 > balance Sheet > short Term Investments

90243000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

127740000

Quarters > 1 > balance Sheet > property Plant Equipment

32104000

Quarters > 1 > balance Sheet > total Assets

162972000

Quarters > 1 > balance Sheet > payables

3292000

Quarters > 1 > balance Sheet > short Term Debt

2953000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

29600000

Quarters > 1 > balance Sheet > equity

133372000

Quarters > 1 > cash Flow > net Income

-31217000

Quarters > 1 > cash Flow > depreciation

-521000

Quarters > 1 > cash Flow > change In Working Capital

58000

Quarters > 1 > cash Flow > cash From Operations

-26633000

Quarters > 1 > cash Flow > capital Expenditures

47000

Quarters > 1 > cash Flow > cash From Investing

32953000

Quarters > 1 > cash Flow > cash From Financing

267000

Quarters > 1 > cash Flow > net Change In Cash

6587000

Quarters > 1 > ratios > PE

-0.3427219254839513

Quarters > 1 > ratios > PB

0.3529450671865159

Quarters > 1 > ratios > ROE

-23.405962270941426

Quarters > 1 > ratios > ROA

-19.15482414157033

Quarters > 1 > ratios > FCF

-26680000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

1680000

Quarters > 2 > income Statement > gross Profit

-1680000

Quarters > 2 > income Statement > operating Expenses

29885000

Quarters > 2 > income Statement > operating Income

-29885000

Quarters > 2 > income Statement > interest Expense

0

Quarters > 2 > income Statement > pretax Income

-28214000

Quarters > 2 > income Statement > net Income

-28214000

Quarters > 2 > income Statement > eps

-0.3098007590437028

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

91071436

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-26534000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

1671000

Quarters > 2 > balance Sheet > cash

28133000

Quarters > 2 > balance Sheet > short Term Investments

122306000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

153563000

Quarters > 2 > balance Sheet > property Plant Equipment

34491000

Quarters > 2 > balance Sheet > total Assets

191271000

Quarters > 2 > balance Sheet > payables

4403000

Quarters > 2 > balance Sheet > short Term Debt

2983000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

29825000

Quarters > 2 > balance Sheet > equity

161446000

Quarters > 2 > cash Flow > net Income

-28214000

Quarters > 2 > cash Flow > depreciation

1680000

Quarters > 2 > cash Flow > change In Working Capital

-1695000

Quarters > 2 > cash Flow > cash From Operations

-25397000

Quarters > 2 > cash Flow > capital Expenditures

1492000

Quarters > 2 > cash Flow > cash From Investing

-2861000

Quarters > 2 > cash Flow > cash From Financing

-104000

Quarters > 2 > cash Flow > net Change In Cash

-28362000

Quarters > 2 > ratios > PE

-0.3098007590437028

Quarters > 2 > ratios > PB

0.29152607140963543

Quarters > 2 > ratios > ROE

-17.475812345923714

Quarters > 2 > ratios > ROA

-14.750798605120483

Quarters > 2 > ratios > FCF

-26889000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

6506000

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

3253000

Quarters > 3 > income Statement > operating Expenses

30743000

Quarters > 3 > income Statement > operating Income

-30743000

Quarters > 3 > income Statement > interest Expense

1000

Quarters > 3 > income Statement > pretax Income

-28727000

Quarters > 3 > income Statement > net Income

-28727000

Quarters > 3 > income Statement > eps

-0.3269394052461557

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

87866435

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-27103000

Quarters > 3 > income Statement > operating Margin

-472.53304641869045

Quarters > 3 > income Statement > total Other Income Expense Net

2016000

Quarters > 3 > balance Sheet > cash

56495000

Quarters > 3 > balance Sheet > short Term Investments

119808000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

180136000

Quarters > 3 > balance Sheet > property Plant Equipment

36752000

Quarters > 3 > balance Sheet > total Assets

220219000

Quarters > 3 > balance Sheet > payables

4830000

Quarters > 3 > balance Sheet > short Term Debt

3132000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

33610000

Quarters > 3 > balance Sheet > equity

186609000

Quarters > 3 > cash Flow > net Income

-28727000

Quarters > 3 > cash Flow > depreciation

1623000

Quarters > 3 > cash Flow > change In Working Capital

-206000

Quarters > 3 > cash Flow > cash From Operations

-24101000

Quarters > 3 > cash Flow > capital Expenditures

176000

Quarters > 3 > cash Flow > cash From Investing

-22120000

Quarters > 3 > cash Flow > cash From Financing

137000

Quarters > 3 > cash Flow > net Change In Cash

-46084000

Quarters > 3 > ratios > PE

-0.3269394052461557

Quarters > 3 > ratios > PB

0.24333967604992257

Quarters > 3 > ratios > ROE

-15.394220000107175

Quarters > 3 > ratios > ROA

-13.044741825183111

Quarters > 3 > ratios > FCF

-24277000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-3.731478635106056

Quarters > 3 > health Score

34

Valuation > metrics > PE

-0.2948407350624567

Valuation > metrics > PB

0.4313049476388558

Valuation > final Score

70

Valuation > verdict

56.9% Undervalued

Profitability > metrics > ROE

-24.60647596708875

Profitability > metrics > ROA

-25.218322158994873

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.28712136482747247

Risk > metrics > Interest Coverage

-2329.3333333333335

Risk > final Score

-9257

Risk > verdict

High

Liquidity > metrics > Current Ratio

14.101430084745763

Liquidity > metrics > Quick Ratio

14.101430084745763

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-18

Prev Risks > 1

-11

Prev Risks > 2

-122912

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T00:23:23.030Z